Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Swedish Growth Companies With High Insider Ownership In July 2024

In This Article:

As global markets navigate through a mix of challenges and opportunities, Sweden's market remains a focal point for investors looking for growth. Amidst this backdrop, companies with high insider ownership in Sweden could offer unique advantages, as such ownership often aligns with long-term commitment to company success in unpredictable times.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

24.8%

Biovica International (OM:BIOVIC B)

18.7%

73.8%

Magle Chemoswed Holding (OM:MAGLE)

14.9%

72.2%

Sileon (OM:SILEON)

20.3%

109.3%

KebNi (OM:KEBNI B)

37.8%

90.4%

Yubico (OM:YUBICO)

37.5%

43.8%

BioArctic (OM:BIOA B)

34%

50.9%

Calliditas Therapeutics (OM:CALTX)

11.6%

52.9%

edyoutec (NGM:EDYOU)

14.6%

63.1%

SaveLend Group (OM:YIELD)

23.3%

103.4%

Click here to see the full list of 93 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (ticker: OM:BIOA B) is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market capitalization of SEK 20.67 billion.

Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.

Insider Ownership: 34%

Earnings Growth Forecast: 50.9% p.a.

BioArctic, a Swedish biopharmaceutical company, is poised for significant growth with its Alzheimer's treatment, Leqembi, recently approved in Hong Kong and other major markets. Despite a recent quarterly loss (SEK 57.56 million), the firm's revenue is expected to grow by 41% annually. Analysts predict a substantial rise in stock price (57.4%) and BioArctic trades at 67.2% below estimated fair value, indicating potential upside. However, insider transactions have not shown substantial buying activity recently.

OM:BIOA B Earnings and Revenue Growth as at Jul 2024
OM:BIOA B Earnings and Revenue Growth as at Jul 2024

Sectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sectra AB (publ) specializes in medical IT and cybersecurity solutions across Sweden, the United Kingdom, the Netherlands, and other European countries, with a market capitalization of SEK 47.13 billion.

Operations: Sectra's revenue is primarily generated from its Imaging IT Solutions segment, which earned SEK 2.55 billion, followed by Secure Communications at SEK 367.35 million and Business Innovation contributing SEK 89.87 million.